#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
medScope.pro

News

alergie

News in the Treatment of Allergic Rhinitis

27. 4. 2022 Source: Life Without Allergic Rhinitis

According to literary sources, 17–28.5% of Europeans suffer from allergic rhinitis (AR), which negatively affects the quality of daily life. Below, we summarize the new recommendations from ARIA (Allergic Rhinitis and its Impact on Asthma) from 2019 regarding the treatment of this condition and highlight a new therapeutic option offered by the fixed combination of mometasone furoate with olopatadine hydrochloride.

alergie rýma

Benefits of Combining Olopatadine and Mometasone in the Treatment of Allergic Rhinitis

Ryaltris is indicated for adults and adolescents aged 12 years and older for the treatment of moderate to severe nasal symptoms associated with allergic rhinitis (AR). The active ingredient of the…
27. 4. 2022 Source: Life Without Allergic Rhinitis
alergie rýma glenmark

Efficacy and Safety of Fixed Combination of Olopatadine and Mometasone in Nasal Spray for Treatment of Seasonal Allergic Rhinitis

Patients with allergic rhinitis require medications with rapid onset and long duration of action. The combination of intranasal antihistamines and corticosteroids has proven effective in the past.…
27. 4. 2022 Source: Life Without Allergic Rhinitis
nemocnice kardiologie

Luck in Unluckiness: Influence of Anticoagulant Therapy on Severity of Stroke in Atrial Fibrillation

A recent Swiss study evaluated the severity, complications, and outcomes of cerebrovascular accidents (CVAs) in patients with atrial fibrillation considering prior anticoagulant therapy use and its…
25. 4. 2022 Source: Anticoagulant Treatment
měření KT

Gliflozins Successfully Treat Type 2 Diabetes Mellitus and Heart Failure

The number of patients with type 2 diabetes mellitus (DM2) and heart failure is increasing worldwide, and the combination of both diseases significantly worsens the prognosis of patients. One of the…
25. 4. 2022 Source: Heart Failure
Ekzém na rukou

New Drug in the Biologic Therapy Arsenal for Plaque Psoriasis

Bimekizumab shows promising effects in clinical studies with psoriasis patients. Let's take a closer look at this recently approved drug in our brief summary.
25. 4. 2022 Source: Psoriasis
pulmonary exacerbation of cystic fibrosis

Ceftaroline vs. Vancomycin in the Treatment of Acute Pulmonary Exacerbation of Cystic Fibrosis

Up to 25% of patients with cystic fibrosis are colonized with methicillin-resistant Staphylococcus aureus (MRSA). The first-line drug for acute pulmonary exacerbation is vancomycin. The study…
22. 4. 2022 Source: Anti-Infectives
nádor tlustého střeva

Safety of Long-Term Therapy with Bevacizumab in Oncological Patients

The angiogenesis inhibitor bevacizumab is typically administered long-term. Therefore, a study published in the journal The Oncologist deals specifically with its long-term safety and tolerability in…
21. 4. 2022 Source: Oncological Treatment
lidé ulice 2

Effectiveness of Idarucizumab Reversal Effect

It is, of course, a great advantage if doctors have a specific substance available that counteracts the effect of oral anticoagulants in urgent need. Idarucizumab is a humanized monoclonal antibody…
21. 4. 2022 Source: Anticoagulant Treatment
lék proti bolesti infografika

Pain Management After Day Surgery

Effective pain control is a crucial part of recovery for patients after painful surgical procedures. In clinical practice, combined analgesia using paracetamol and nonsteroidal anti-inflammatory…
21. 4. 2022 Source: Analgesia
Chronic lymphocytic leukemia (CLL)

Venetoclax Treatment Strategies in Patients with CLL

One of the new targeted preparations in the treatment of chronic lymphocytic leukemia (CLL) is the Bcl-2 inhibitor venetoclax. Its significant advantage is the potential to achieve deep remission,…
20. 4. 2022 Source: Chronic Lymphocytic Leukemia
Onkology1

Efficacy of Lorlatinib in Patients with ROS1-Positive NSCLC in Clinical Practice

Interesting real-world data have been brought by a study on the efficacy of lorlatinib in patients with non-small cell lung cancer (NSCLC) with a mutation in the ROS1 gene.
20. 4. 2022 Source: Genetic Profile and Treatment of NSCLC
Muž_dýchání_lékařka

Interactive Case Study: AATD –⁠ Alpha-1-Antitrypsin Deficiency

We present a case study of a man who was 41 years old at the time of his first contact with a pulmonary doctor. He came with symptoms of allergic seasonal rhinoconjunctivitis, proven sensitivity to…
19. 4. 2022 Source: Deficiency of Alpha-1-Antitrypsin
Streptococcus mutans2

Probiotics as a Means to Reduce the Incidence of Streptococcus Mutans

Data from a prospective study examining the effects of probiotics on the oral microbiome show the ability of orally administered probiotics to reduce the incidence of Streptococcus mutans and also…
19. 4. 2022 Source: GI, colic and microbiome
Treatment of Knee Pain and Arthritis

Long-term Efficacy of Targeted Therapy for Axial Spondyloarthritis

How does etanercept fare in the long-term treatment of early axial spondyloarthritis (axSpA)? Data from over 10 years of follow-up in patients with both radiographic and non-radiographic forms of…
19. 4. 2022 Source: Arthritis
1 … 54 55 56 57 58 … 115
Filter by speciality
Remove filters
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#